home

Johnson & Johnson Reports 2016 First-Quarter Results:

EVENTSinvestor.jnj2016-04-20 14:11 Read   73

Sales of $17.5 Billion Increased 0.6% Versus 2015 First Quarter

Intrexon Forms Two New Collaborations with Harvest Intrexon Enterprise Fund

EVENTSprnewswire2016-04-20 14:02 Read   79

ntrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced it has entered into Exclusive Channel Collaborations (ECC) with two startups backed by the Harvest Intrexon Enterprise Fund, sponsored by Harvest Capital Strategies, LLC.  

Recipharm AB: Recipharm creates a global CDMO leader through SEK 1.7 billion strategic acquisitions in the US, Sweden and India

EVENTSbusinesswire2016-04-20 13:58 Read   115

Recipharm AB (publ) (“Recipharm” or the “Company”) announces today that it has signed two separate agreements to acquire Kemwell’s pharmaceutical contract development and manufacturing (CDMO) businesses.

Valeant CEO Deposed for at Least Nine Hours by Senate Committee

EVENTSbloomberg2016-04-20 13:38 Read   69

Valeant Pharmaceuticals International Inc. outgoing Chief Executive Officer Mike Pearson was deposed for at least nine hours on Monday by a Senate committee that’s investigating his company’s drug pricing practices, ahead of a public hearing later this month.

Sanofi expands biologics plant, adding 100 workers

Trendfiercepharma2016-04-20 13:26 Read   67

Sanofi ($SNY) turned to Boehringer Ingelheim last year to get the added manufacturing capacity it figured it would need for a host of new monoclonal antibodies (mAbs) it was developing with partner Regeneron ($REGN).

MS patent challenges put billions in Biogen sales at risk

EVENTSfiercepharma2016-04-20 13:23 Read   75

Biogen, already battling in a patent fight over multiple sclerosis star Tecfidera, has run into another challenge--this time with fellow MS treatment Tysabri.

NTU scientists invent bubble technology which can shoot drugs deep into tumours

Frontiermedia.ntu.edu.2016-04-20 13:17 Read   66

Scientists at Nanyang Technological University (NTU Singapore) have invented a new way to deliver cancer drugs deep into tumour cells.

Exclusive: Lonza in bid to acquire Catalent - sources

EVENTSreuters2016-04-20 13:09 Read   71

Swiss specialty chemicals and life sciences company Lonza Group AG (LONN.S) has offered to acquire U.S. drug delivery technology company Catalent Inc (CTLT.N), three people familiar with the matter said this week.

Roche sues Intas Pharma over Mircera anaemia drug patent

EVENTSeconomictimes2016-04-20 13:04 Read   139

MUMBAI: Swiss biotechnology giant Roche has sued Ahmedabad-based drug maker Intas Pharmaceuticals in Delhi High Court, alleging infringement of its patent rights over Mircera, an injectable brand used to treat patients with anaemia in chronic kidney-related ailments. 

Impax, AmerisourceBergen unit recall more than 35M fenofibrate capsules

Frontierfiercepharma2016-04-20 12:57 Read   106

Labeling issues are at the root of four nationwide recalls affecting more than 35 million fenofibrate capsules from Impax Laboratories and a unit of AmerisourceBergen ($ABC).

Vitamin D deficiency linked to sex-specific hypoglycemia frequency, adverse cardiometabolic control

FrontierHealio2016-04-20 11:26 Read   63

In children and adolescents with type 1 diabetes, vitamin D deficiency is prevalent and may be linked to the frequency of hypoglycemic episodes and adverse cardiometabolic control in boys, according to study findings.

Nuvigil improves hallucinations, agitation, apathy in Lewy body dementia

Frontierhealio2016-04-20 11:22 Read   74

Nuvigil significantly improved overall neuropsychiatric symptoms of dementia with Lewy bodies, particularly visual hallucinations, agitation and apathy, according to data presented at the American Academy of Neurology Annual Meeting.